Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
Saved in:
| Title: | Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group. |
|---|---|
| Authors: | Peyrade F; Centre Antoine Lacassagne, Nice, France. Electronic address: frederic.peyrade@nice.unicancer.fr., Bologna S; Centre Hospitalier Nancy-Brabois, Vandoeuvre, France., Delwail V; Hematology, University Hospital, Poitiers, France., Emile JF; Pathology Department, Hôpital Ambroise Paré, Boulogne, France., Pascal L; Hôpital Saint-Vincent de Paul, Lille, France., Fermé C; Institut Gustave Roussy, Villejuif, France., Schiano JM; Institut Paoli Calmettes, Marseille, France., Coiffier B; Hematology Department, Centre Hospitalier Lyon-Sud, Pierre-Benite Cedex, France., Corront B; Hematology, General Hospital, Annecy, France., Farhat H; Hematology, Hôpital de Versailles, Le Chesnay, France., Fruchart C; Hematology Department, François Baclesse Cancer Center, Caen, France., Ghesquieres H; Onco-Hematology, Centre Léon Bérard, Lyon, France., Macro M; Hematology, Hôpital Côte de Nacre, CHU, Caen, France., Tilly H; Hematology Unit, Centre Henri Becquerel, Rouen, France., Choufi B; Centre Hospitalier de Boulogne, Boulogne, France., Delarue R; Hematology Unit, AP-HP, Hôpital Necker, Paris, France., Fitoussi O; Polyclinique Bordeaux Aquitaine, Bordeaux, France., Gabarre J; Hematology, Hôpital Pitié-Salpêtrière, Paris, France., Haioun C; Hematology, Hôpital Henri Mondor, Créteil Cedex, France., Jardin F; Hematology Unit, Centre Henri Becquerel, Rouen, France. |
| Source: | The Lancet. Haematology [Lancet Haematol] 2017 Jan; Vol. 4 (1), pp. e46-e55. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28041583 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Peyrade+F%22">Peyrade F</searchLink>; Centre Antoine Lacassagne, Nice, France. Electronic address: frederic.peyrade@nice.unicancer.fr.<br /><searchLink fieldCode="AU" term="%22Bologna+S%22">Bologna S</searchLink>; Centre Hospitalier Nancy-Brabois, Vandoeuvre, France.<br /><searchLink fieldCode="AU" term="%22Delwail+V%22">Delwail V</searchLink>; Hematology, University Hospital, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Emile+JF%22">Emile JF</searchLink>; Pathology Department, Hôpital Ambroise Paré, Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Pascal+L%22">Pascal L</searchLink>; Hôpital Saint-Vincent de Paul, Lille, France.<br /><searchLink fieldCode="AU" term="%22Fermé+C%22">Fermé C</searchLink>; Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Schiano+JM%22">Schiano JM</searchLink>; Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Coiffier+B%22">Coiffier B</searchLink>; Hematology Department, Centre Hospitalier Lyon-Sud, Pierre-Benite Cedex, France.<br /><searchLink fieldCode="AU" term="%22Corront+B%22">Corront B</searchLink>; Hematology, General Hospital, Annecy, France.<br /><searchLink fieldCode="AU" term="%22Farhat+H%22">Farhat H</searchLink>; Hematology, Hôpital de Versailles, Le Chesnay, France.<br /><searchLink fieldCode="AU" term="%22Fruchart+C%22">Fruchart C</searchLink>; Hematology Department, François Baclesse Cancer Center, Caen, France.<br /><searchLink fieldCode="AU" term="%22Ghesquieres+H%22">Ghesquieres H</searchLink>; Onco-Hematology, Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Macro+M%22">Macro M</searchLink>; Hematology, Hôpital Côte de Nacre, CHU, Caen, France.<br /><searchLink fieldCode="AU" term="%22Tilly+H%22">Tilly H</searchLink>; Hematology Unit, Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Choufi+B%22">Choufi B</searchLink>; Centre Hospitalier de Boulogne, Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Delarue+R%22">Delarue R</searchLink>; Hematology Unit, AP-HP, Hôpital Necker, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fitoussi+O%22">Fitoussi O</searchLink>; Polyclinique Bordeaux Aquitaine, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Gabarre+J%22">Gabarre J</searchLink>; Hematology, Hôpital Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Haioun+C%22">Haioun C</searchLink>; Hematology, Hôpital Henri Mondor, Créteil Cedex, France.<br /><searchLink fieldCode="AU" term="%22Jardin+F%22">Jardin F</searchLink>; Hematology Unit, Centre Henri Becquerel, Rouen, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101643584%22">The Lancet. Haematology</searchLink> [Lancet Haematol] 2017 Jan; Vol. 4 (1), pp. e46-e55. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101643584 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3026 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523026%22">23523026 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28041583 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2352-3026(16)30171-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e46 Titles: – TitleFull: Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peyrade F – PersonEntity: Name: NameFull: Bologna S – PersonEntity: Name: NameFull: Delwail V – PersonEntity: Name: NameFull: Emile JF – PersonEntity: Name: NameFull: Pascal L – PersonEntity: Name: NameFull: Fermé C – PersonEntity: Name: NameFull: Schiano JM – PersonEntity: Name: NameFull: Coiffier B – PersonEntity: Name: NameFull: Corront B – PersonEntity: Name: NameFull: Farhat H – PersonEntity: Name: NameFull: Fruchart C – PersonEntity: Name: NameFull: Ghesquieres H – PersonEntity: Name: NameFull: Macro M – PersonEntity: Name: NameFull: Tilly H – PersonEntity: Name: NameFull: Choufi B – PersonEntity: Name: NameFull: Delarue R – PersonEntity: Name: NameFull: Fitoussi O – PersonEntity: Name: NameFull: Gabarre J – PersonEntity: Name: NameFull: Haioun C – PersonEntity: Name: NameFull: Jardin F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2017 Jan Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2352-3026 Numbering: – Type: volume Value: 4 – Type: issue Value: 1 Titles: – TitleFull: The Lancet. Haematology Type: main |
| ResultId | 1 |